Crown Crafts, Inc. Key Metrics

2 years of history · ending 2025-03-30 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

M-Score (Beneish; >-1.78 flags risk)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$-1
Book Value Per Share
$4
Free Cash Flow Per Share
$1
Cash Per Share
$0
Revenue Per Share
$8
OCF Per Share
$1
Return on Equity
-20.5%
Return on Assets
-11.4%
Return on Invested Capital
-15.3%
Debt to Equity
0.42
Current Ratio
3.57
Quick Ratio
1.77
Asset Turnover
1.06
Days Sales Outstanding
102.49
Days Payables Outstanding
28.90
Days Inventory On Hand
153.78
Cash Conversion Cycle
227.37
SBC / Revenue
0.9%
Capex / Revenue
1.0%
Working Capital
$40M
Net Current Asset Value
$55M
Invested Capital
$56M
OCF / Net Income
-1.05
FCF / Net Income
-0.96
Accruals Ratio (Sloan)
-23.6%
Net Debt
$16M
Net Debt / EBITDA
-1.52
Interest Coverage
9.54
Cash Coverage
-8.37
Dividend Coverage
2.99
Capex Coverage
11.26
Tangible Common Equity
$33M
TCE / Total Assets
40.1%
Goodwill / Total Assets
0.0%
NOPAT
$-9M
Cash ROIC
15.5%
WC / Revenue
45.6%
Capex / D&A
1.24
Reinvestment Rate
-147.1%
Total Payout Ratio
-35.1%
Asset Growth vs Revenue Growth
-1.4%
Revenue 5Y CAGR
3.5%
EPS 5Y CAGR
-0.5%
FCF 5Y CAGR
2.7%
EBITDA 5Y CAGR
-0.1%
Book Value 5Y CAGR
-1.4%
Stock Price (FY-end)
$3
Market Cap
$34M
P/E Ratio
8.88
P/S Ratio
0.39
P/B Ratio
0.86
P/TB Ratio
1.05
P/OCF Ratio
3.49
P/FCF Ratio
3.83
Enterprise Value
$50M
EV / EBITDA
6.56
EV / Sales
0.58
EV / FCF
5.62
FCF Yield
26.1%
Dividend Yield
9.6%
Shareholder Yield
7.4%
Buyback Yield
0.0%
Capex Yield
2.5%
Dividend Per Share
$0
DPS YoY Growth
-0.1%
Operating Leverage
-0.23
Graham Number
$7
Shares Variation (YoY)
1.5%
Beta (5Y)
0.25
Cost of Equity
5.8%
Cost of Debt (after tax)
-5.6%
WACC
2.1%
ROIC - WACC Spread
-17.3%
52W High
$4
52W Low
$3
Trailing Return 1Y
-24.8%
Trailing Return 5Y
15.8%
F-Score (Piotroski)
3.00
M-Score (Beneish)
-3.95

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

Stock Price on Earnings Dates

Crown Crafts, Inc. — Effective Tax Rate ReconciliationNEW

Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.

Effective Rate Trend

Reconciliation LineFY2020FY2021FY2022FY2023FY2024FY2025
Federal Statutory Rate21.00%21.00%21.00%21.00%21.00%21.00%
State & Local Income Taxes3.60%1.70%4.20%
Foreign Rate Differential
Other Adjustments
Tax Law Change
Effective Tax Rate15.50%21.30%19.50%23.90%21.40%24.60%

Cash vs Accrual

ItemFY2020FY2021FY2022FY2023FY2024FY2025
Income Tax Expense (Accrual)$1.2M$1.6M$2.4M$1.8M$1.3M−$3.1M
Income Taxes Paid (Cash)

Crown Crafts, Inc. — M&A AcquisitionsNEW

Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.

Baby Boom

Total Consideration

$18.0M

Purchase-Price Allocation

Goodwill

$5.8M

Liabilities Assumed

$601.0K

Pro-Forma Combined Entity

Revenue

$92.3M

Net Income

+$8.6M